Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial.
Thierry Conroy
No relevant relationships to disclose
Marie-Pierre Galais
No relevant relationships to disclose
Jean Luc Raoul
No relevant relationships to disclose
Olivier Bouche
No relevant relationships to disclose
Sophie Gourgou-Bourgade
No relevant relationships to disclose
Jean-Yves Douillard
No relevant relationships to disclose
Pierre-Luc Etienne
No relevant relationships to disclose
Valérie Boige
No relevant relationships to disclose
Isabelle Martel-Lafay
No relevant relationships to disclose
Pierre Michel
No relevant relationships to disclose
Carmen Llacer-Moscardo
No relevant relationships to disclose
Jocelyne Berille
Research Funding - Sanofi
Laurent Bedenne
No relevant relationships to disclose
Antoine Adenis
No relevant relationships to disclose